Annual Retained Earnings
-$159.88 M
-$8.50 M-5.62%
June 1, 2024
Summary
- As of February 10, 2025, KTRA annual retained earnings is -$159.88 million, with the most recent change of -$8.50 million (-5.62%) on June 1, 2024.
- During the last 3 years, KTRA annual retained earnings has fallen by -$48.65 million (-43.74%).
Performance
KTRA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$159.88 M
-$2.33 M-1.48%
June 1, 2024
Summary
- As of February 10, 2025, KTRA quarterly retained earnings is -$159.88 million, with the most recent change of -$2.33 million (-1.48%) on June 1, 2024.
- Over the past year, KTRA quarterly retained earnings has dropped by -$4.34 million (-2.79%).
Performance
KTRA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
KTRA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.6% | -2.8% |
| 3 y3 years | -43.7% | -33.6% |
| 5 y5 years | -163.9% | -33.6% |
KTRA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +43.7% | at low | +27.3% | at low |
| 5 y | 5-year | +163.9% | at low | +150.1% | at low |
| alltime | all time | >+9999.0% | at low | >+9999.0% | at low |
Kintara Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | -$159.88 M(+5.6%) | -$159.88 M(+1.5%) |
| Mar 2024 | - | -$157.55 M(+1.3%) |
| Dec 2023 | - | -$155.54 M(+0.7%) |
| Sep 2023 | - | -$154.51 M(+2.1%) |
| Jun 2023 | -$151.38 M(+11.0%) | -$151.38 M(+2.3%) |
| Mar 2023 | - | -$148.04 M(+2.3%) |
| Dec 2022 | - | -$144.77 M(+2.4%) |
| Sep 2022 | - | -$141.32 M(+3.6%) |
| Jun 2022 | -$136.36 M(+22.6%) | -$136.36 M(+4.2%) |
| Mar 2022 | - | -$130.91 M(+4.3%) |
| Dec 2021 | - | -$125.55 M(+4.9%) |
| Sep 2021 | - | -$119.66 M(+7.6%) |
| Jun 2021 | -$111.22 M(+59.5%) | -$111.22 M(+6.4%) |
| Mar 2021 | - | -$104.49 M(+6.8%) |
| Dec 2020 | - | -$97.85 M(+5.9%) |
| Sep 2020 | - | -$92.43 M(+32.6%) |
| Jun 2020 | -$69.72 M(+15.1%) | -$69.72 M(+5.8%) |
| Mar 2020 | - | -$65.89 M(+3.1%) |
| Dec 2019 | - | -$63.93 M(+2.8%) |
| Sep 2019 | - | -$62.19 M(+2.7%) |
| Jun 2019 | -$60.58 M(+15.5%) | -$60.58 M(+4.5%) |
| Mar 2019 | - | -$57.99 M(+3.0%) |
| Dec 2018 | - | -$56.30 M(+3.4%) |
| Sep 2018 | - | -$54.47 M(+3.9%) |
| Jun 2018 | -$52.44 M(+27.5%) | -$52.44 M(+4.8%) |
| Mar 2018 | - | -$50.03 M(+6.3%) |
| Dec 2017 | - | -$47.05 M(+7.3%) |
| Sep 2017 | - | -$43.83 M(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | -$41.12 M(+27.5%) | -$41.12 M(+7.1%) |
| Mar 2017 | - | -$38.40 M(+5.7%) |
| Dec 2016 | - | -$36.32 M(+4.3%) |
| Sep 2016 | - | -$34.84 M(+8.1%) |
| Jun 2016 | -$32.24 M(+73.2%) | -$32.24 M(+34.2%) |
| Mar 2016 | - | -$24.03 M(+5.0%) |
| Dec 2015 | - | -$22.89 M(+13.1%) |
| Sep 2015 | - | -$20.24 M(+8.7%) |
| Jun 2015 | -$18.61 M(-0.3%) | -$18.61 M(-18.1%) |
| Mar 2015 | - | -$22.72 M(+7.8%) |
| Dec 2014 | - | -$21.06 M(+5.4%) |
| Sep 2014 | - | -$19.99 M(+4.8%) |
| Jun 2014 | -$18.66 M(+17.6%) | - |
| Mar 2014 | - | -$19.06 M(+20.2%) |
| Dec 2013 | -$15.86 M(>+9900.0%) | -$15.86 M(+5.8%) |
| Sep 2013 | - | -$15.00 M(-31.2%) |
| Jun 2013 | - | -$21.79 M(+45.5%) |
| Mar 2013 | - | -$14.98 M(>+9900.0%) |
| Dec 2012 | - | -$65.00 K(+5.2%) |
| Sep 2012 | - | -$61.80 K(+7.3%) |
| Jun 2012 | - | -$57.60 K(+1.8%) |
| Jun 2012 | -$57.60 K(+48.8%) | - |
| Mar 2012 | - | -$56.60 K(+5.8%) |
| Dec 2011 | - | -$53.50 K(+25.6%) |
| Sep 2011 | - | -$42.60 K(+10.1%) |
| Jun 2011 | -$38.70 K(+591.1%) | -$38.70 K(+21.3%) |
| Mar 2011 | - | -$31.90 K(+13.5%) |
| Dec 2010 | - | -$28.10 K(+401.8%) |
| Jun 2010 | -$5600.00 | -$5600.00 |
FAQ
- What is Kintara Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Kintara Therapeutics?
- What is Kintara Therapeutics annual retained earnings year-on-year change?
- What is Kintara Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly retained earnings year-on-year change?
What is Kintara Therapeutics annual retained earnings?
The current annual retained earnings of KTRA is -$159.88 M
What is the all time high annual retained earnings for Kintara Therapeutics?
Kintara Therapeutics all-time high annual retained earnings is -$5600.00
What is Kintara Therapeutics annual retained earnings year-on-year change?
Over the past year, KTRA annual retained earnings has changed by -$8.50 M (-5.62%)
What is Kintara Therapeutics quarterly retained earnings?
The current quarterly retained earnings of KTRA is -$159.88 M
What is the all time high quarterly retained earnings for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly retained earnings is -$5600.00
What is Kintara Therapeutics quarterly retained earnings year-on-year change?
Over the past year, KTRA quarterly retained earnings has changed by -$4.34 M (-2.79%)